Ocular Therapeutix, Inc. (OCUL)
14.65
-0.76
(-4.93%)
USD |
NASDAQ |
Dec 11, 16:00
14.51
-0.14
(-0.96%)
After-Hours: 20:00
Ocular Therapeutix Total Liabilities (Quarterly): 152.65M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Hologic, Inc. | 3.967B |
| Vertex Pharmaceuticals, Inc. | 7.544B |
| Bristol Myers Squibb Co. | 78.29B |
| Krystal Biotech, Inc. | 102.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 410.88M |
| Shareholders Equity (Quarterly) | 258.23M |
| Debt to Equity Ratio | 0.2982 |
| Current Ratio | 7.850 |
| Net Debt Paydown Yield | -0.02% |